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ehc¸et’s Disease (BD) is a multisystemic inﬂammatory dis-
ase of unknown etiology. Although previously classiﬁed
mong the systemic vasculitides, recent clinical, immunolog-
cal and genetic investigations led to its classiﬁcation within
he autoinﬂammatory disorders,1 even though this classiﬁca-
ion is far from consensual or deﬁnitive.2,3
It is characterized by recurrent oral and genital ulcers,
veitis, arthritis and skin lesions such as erythema nodosum
r pseudofolliculitis.4 In more  severe cases it may also
ourse with gastrointestinal, pulmonary, neurological and
ardiovascular manifestations.5 Cardiac manifestations arePlease cite this article in press as: Madureira P, et al. Intracardiac thrombo
2016. http://dx.doi.org/10.1016/j.rbre.2014.11.002
stimated to be present in 1–6%6 of patients with BD, and
nclude acute myocardial infarction, conduction system
isorders, valvular diseases, pericarditis, endomyocardial
brosis, coronary arteritis and intracardiac thrombosis.5–7
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evidence for its treatment is lacking.6
Case  report
The authors report the case of a male patient, 14 years old,
with a previous history of recurrent oral ulcers, attention
deﬁcit hyperactivity disorder and asthma.
The patient was admitted to the Pediatric ward of our hos-
pital with fever, oral ulcers and red eye that started 2 weeks
previously, and complicated later with cough and right tho-
racic pain. Suspecting pulmonary infection he was startedsis in Behc¸et’s disease: a life threatening event. Rev Bras Reumatol.
on azithromycin for 5 days, but the symptoms kept worsen-
ing with increasing fever spikes and the onset of erythema
nodosum and pseudofolliculitis lesions on his right leg. The
pulmonary x-ray showed a right paracardiac consolidation,
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Fig. 1 – Contrast-enhanced cardiac MRI  with thrombi visible in the right ventricle outﬂow tract (A), and in the right ventricle
(B).
and the patient was then started on ampicillin. Despite the
improvement of the respiratory symptoms, the patient main-
tained daily fever spikes and 3 genital ulcers were then
noticed. Infectious agents were excluded and the autoimmune
lab test panel was negative for ANA, anti-cardiolipins, circu-
lating immune complexes and ANCA. The echocardiography
was normal at that time.
The suggestive clinical picture allied to a positive HLA
B51 determination and pathergy test allowed the diagnosis of
BD. He was started on colchicine 1 mg/day and prednisolone
20 mg/day with resolution of the symptoms.
Three weeks later on a routine echocardiography a
9x21 mm mass adjacent to the left cusp of the pulmonary valve
was detected. On physical examination a soft systolic mur-
mur was heard on upper left sternal edge. On the suspicion
of endocarditis prednisolone dose was reduced to 10 mg/day
and the patient was started on amoxicillin/clavulanate and
gentamicin. Despite the antibiotics a recurrent fever with new
oral ulcers appeared 3 days after the admission, and serial
cardiac ultrasounds kept showing the cardiac mass. Blood cul-
tures were negative. Four weeks after the hospital admission
a new echocardiography showed 2 new lesions on the right
ventricle. Given the absence of response to the treatment, a
contrast-enhanced cardiac magnetic resonance imaging (MRI)
was performed (Fig. 1), showing several intracardiac thrombi
on the right ventricle with an overall 4 cm longitudinal size and
another one on the right ventricle outﬂow tract, protruding
to the pulmonary trunk. There were also signs of pulmonary
thromboembolism on segmental branches of inferior lobar
arteries, 2 occlusive thrombi on the right internal jugular
vein, severe stenosis of the right brachiocephalic vein and aPlease cite this article in press as: Madureira P, et al. Intracardiac thromb
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non-occlusive thrombus of the superior vena cava. Low molec-
ular weight heparin was immediately started and the patient
was submitted to cardiac surgery for excision of the intrac-
ardiac thrombi. Histological examination of the lesions wassuggestive of a chronic inﬂammatory process with myocar-
dial involvement, without evidence of infectious or neoplastic
disease.
With the exclusion of infection and neoplasia, it was
assumed that the intracardiac masses were secondary to
heart involvement by BD. Prednisolone dose was increased
to 1 mg/kg/day and monthly cyclophosphamide pulses
(500 mg/m2), and oral anticoagulation with warfarin, were
started. The patient did not have new fever spikes and the oral
and genital ulcers resolved. Contrast-enhanced cardiac MRI
performed 4 months later showed a complete resolution of
the intracardiac, pulmonary and superior vena cava thrombo-
sis, with residual thrombus seen on the right internal jugular
vein and the right brachiocephalic vein.
Discussion
The authors present a rare case of an adolescent with a recent
diagnosis of BD that is admitted with intracardiac thrombosis,
superior vena cava syndrome and pulmonary thromboem-
bolism. The patient was submitted to surgery to excise the
lesions and has been treated with cyclophosphamide, pred-
nisolone and colchicine achieving complete remission. To our
knowledge there is only one other reported case of intracardiac
thrombosis on an adolescent with BD.8
Cardiac involvement in Behc¸et’s Disease is an uncommon
manifestation with major implications on the disease progno-
sis. On a recent literature review by Geri and colleagues there
were only 22 cases of intracardiac thrombosis reported fromosis in Behc¸et’s disease: a life threatening event. Rev Bras Reumatol.
1992 to 2010; most of the cases occurred in men  and were
limited to the right ventricle and atrium.6 The 5-year survival
rate for these patients is smaller than for that with any other
organs involved in BD (83.6% vs. 95.8%).6
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We  currently know the important role of both the innate
nd adaptive immune systems in the disease pathogenesis,2
ut the pathophysiology of the thrombotic predisposition
mong these patients are still mainly unknown. Several mech-
nisms have been proposed, such as endothelial lesions,
ncreased levels of prothrombotic factors and immune com-
lexes deposition in the blood vessel.9
In the presence of intracardiac lesions it is important to
xclude other diagnoses, such as endocarditis and cardiac
umor, in order to assume heart involvement by BD as the
ause of the lesions. Although transthoracic echocardiography
s an excellent imaging modality to screen and evaluate intrac-
rdiac lesions, in some cases, such as the one presented, it
acks sensitivity on identifying and characterizing the thrombi
hen compared to cardiac MRI.1,10
The evidence for the treatment of intracardiac thrombo-
is in BD is based on case reports or case series available
n the literature, and currently there is no consensus on the
ost effective approach. Most of the cases reported have been
reated with a combination of anticoagulant and immunosup-
ressive agents (azathioprine or cyclophosphamide), which
eems to be associated with higher rates of remission.6 It
hould be noted that in the presence of aneurysm of the pul-
onary artery anticoagulant agents should be avoided or used
ith caution, as they are associated with increased risk of
evere hemoptysis.1,9 Cardiac surgery should be considered on
he cases of extensive or recurrent thrombosis despite medical
reatment, or when it is associated with cardiac congestion.9Please cite this article in press as: Madureira P, et al. Intracardiac thrombo
2016. http://dx.doi.org/10.1016/j.rbre.2014.11.002
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